N-Acetylglucosamine: A New Osmotic Solute in Peritoneal Dialysis Solutions

Abstract

Keywords

N-acetylglucosamine mesothelium

Get full access to this article

View all access options for this article.

References

Coles

G.A.

Biocompatibility of various osmotic solutes.

Perit Dial Int 1995; 15: S71–5.

Vanholder

R.C.

Lameire NH. Osmotic agents in peritoneal dialysis.

Kidney Int 1996; 50(Suppl 56): S86–1.

Dawnay

Advanced glycation end products in peritoneal dialysis.

Perit Dial Int 1996; 16(Suppl 1): S50–3.

, Breborowicz

, Korybalska

Use of N-Acetyl-Glucosamine as osmotic agent for peritoneal dialysis.

Perit Dial Int 1996; 16(Suppl 2): S16.

Yung

, Coles

G.A.

, Williams

J.D.

The source and possible significance of hyaluronan in the peritoneal cavity.

Kidney Int 1994; 46: 527–33.

Jackson

R.L.

, Busch

S.J.

, Cardin

A.D.

Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes.

Physiol Rev 1991; 71: 481–532.

Comper

W.D.

, Laurent

T.C.

Physiological function of connective tissue polysaccharides.

Physiol Rev 1978; 58: 255–325.

Weigel

P.H.

, Frost

S.J.

, LeBoeuf

The specific interaction between fibrin(ogen) and hyaluronan: possible consequences in haemostasis, inflammation and wound healing. In: Evered

, Whelan

, eds. The biology of hyaluronan. Chichester: Wiley (Ciba Foundation Symposium 143) 1989; 248–64.

Wieczorowska

, Breborowicz

, Martis

Protective effect of hyaluronic acid against peritoneal injury.

Perit Dial Int 1995; 15: 81–3.

10.

, Wieczorowska-Tobis

, Tam

N-Acetyl Glucosamine (NAG) protects peritoneum of rats on chronic peritoneal dialysis.

Perit Dial Int 1997; 17: (Suppl 1): S10.

11.

Breborowicz

, Radkowski

, Knapowski

Effects of chondroitin sulphate on fluid and solute transport during peritoneal dialysis in rats.

Perit Dial Int 1991; 11: 351–4.

12.

Hain

, Kessel

Aspects of new solutions for peritoneal dialysis.

Nephrol Dial Transpl 1987; 2: 67–72.

13.

Levin

R.M.

, Krieger

N.N.

, Wiznler

R.J.

Glucosamine and acetylglucosamine tolerance in man.

J Lab Clin Med 1961; 58: 927–32.

14.

Weiden

, Wood

I.J.

The fate of glucosamine hydrochloride injected intravenously in man.

J Clin Pathol 1958; 11: 343–9.

15.

Kohn

, Winzler

R.J.

, Hoffman

R.C.

Metabolism of D-Glucosamine and N-Acetyl-D-glucosamine in the intact rat.

J Biol Chem 1962; 237: 304–8.

16.

Breborowicz

, Wieczorowska

, Martis

Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats.

Nephron 1994; 67: 346–50.

17.

Bazzato

, Fracasso

, Re

Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis.

Lancet 1995; 346: 740–1.

18.

Mistry

C.D.

, Mallick

N.P.

, Gokal

Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges.

Lancet 1987; 2: 178–82.

19.

Westergren-Thorsson

, Onnervik

P.O.

, Franson

L.A.

Proliferation of cultured fibroblasts is inhibited by 1-iduronate-containing glycosaminoglycans.

J Cell Physiol 1991; 147: 523–30.

20.

Gambaro

, Fracasso

, Re

Glycosaminoglycans improve peritoneal transport and fibrosis in rats with peritoneal sclerosis induced by diethylexylphtalate.

J Am Soc Nephrol 1994; 5: 448.